Guardant Health
GH
#2529
Rank
โ‚ฌ5.09 B
Marketcap
41,27 โ‚ฌ
Share price
-1.56%
Change (1 day)
148.46%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2023 (TTM): -4,68 โ‚ฌ

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -4,56 โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -5,94 โ‚ฌ a decrease over its 2021 EPS that were of -3,71 โ‚ฌ.

EPS history for Guardant Health from 2018 to 2023

2019202020212022-โ‚ฌ5-โ‚ฌ4-โ‚ฌ3-โ‚ฌ2-โ‚ฌ1โ‚ฌ10companiesmarketcap.com

Annual EPS

Year EPS Change
2023 (TTM)-4,68 โ‚ฌ-21.18%
2022-5,94 โ‚ฌ60%
2021-3,71 โ‚ฌ55.04%
2020-2,40 โ‚ฌ207.14%
2019-0,78 โ‚ฌ-19.81%
2018-0,97 โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-4,48 โ‚ฌ-1.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-0,11 โ‚ฌ-97.57%๐Ÿ‡บ๐Ÿ‡ธ USA